Reprints
PubMed
CAVEAT LECTOR
REGULATION OF TRANSCRIPTION FACTOR NF KAPPA B IN IMMUNE SENESCENCE
Department of Geriatrics, Medicine, Microbiology and Immunology, University of Arkansas for Medical Sciences, and GRECC, John L. McClellan Memorial VA hospital, VA Medical Research, GC143, 151/LR, 4300 West 7th street, Little Rock, Arkansas 72205
Received 1/15/97 Accepted 1/29/98
8. REFERENCES
1. Martin, G.R., Banner, D.B., and Holbrook, N.J. Aging-causes and defenses. Annu. Rev. Med. 44:419-429 (1993).
2. Miller, R.A. Aging and immune function. Int. Rev. Cytol. 124:187-215 (1992).
3. Miller, R.A. The aging immune system: primer and prospectus. Science. 273:70-74. (1996).
4. Ben-Yehuda, A., and Weksler, M.E.Host resistance and the immune system. Clin. Geriat. Med. 8:701-711 (1992).
5. Makinodan, T., and Kay, M.M.B. Age influence on the immune system. Adv.Immunol. 29:287-330 (1980).
6. Orme, I.M. Aging and immunity to tuberculosis: increased susceptibility of old mice reflects a decreased capacity to generate mediator T lymphocytes. J. Immunol. 38:4414-4418 (1987).
7. Makinodan, T., James, S.J., Inamizu, T., and Chang, M.P. Immunologic basis for susceptibility to infection in the aged. Gerontol. 30:279-289 (1984).
8. Dunn, P.L., and North, R.J. Effect of advanced ageing on the ability of mice to cause tumor regression in response to immunotherapy. Immunology 74:355- 359 (1991).
9. Flood, P.M., Urban, J.L., Kripke, M.L., and Schreiber, H. Loss of tumor-specific and idiotype-specific immunity with age. J. Exp. Med. 154:275-290 (1981).
10. Good, R.A., and Yunis, E. Association of autoimmunity, immunodeficiency and aging in man, rabbits, and mice. Fed. Proc. 33:2040-2050 (1974).
11. Teague, P.O. Spontaneous autoimmunity and involution of the lymphoid system. Fed. Proc. 33:2051-2052 (1974).
12. Tollefsbol, T.O., and Cohen, H.J. Expression of intracellular biochemical defects of lymphocytes in aging: proposal of a general aging mechanism which is not cell-specific. Exp. Gerontol. 21:129-148 (1986).
13. Weksler, M.E., and Hutteroth, T.H. Impaired lymphocyte function in aged humans. J. Clin. Invest. 53:99-104 (1974).
14. Miller, A.E. Selective decline in cellular immune response to varicella-zoster in the elderly. Neurology 30:582-587 (1980).
15. Roberts-Thomson, I.C., Whittingham, S., Youngchaiyud, U., and Mackay, I.R. Ageing, immune response, and mortality. Lancet 2:368-370 (1974).
16. Goodman, S.A., and Makinodan, T. Effect of age on cell-mediated immunity in long-lived mice. Clin. Exp. Immunol. 19:533-542 (1975).
17. Kishimoto, S., Tomino, S., Mitsuya, H., Fujiwara, H., and Tsuda, H. Age-related decline in the in vitro and in vivo syntheses of anti-tetanus toxoid antibody in humans. J. Immunol. 125:2347-2352 (1980).
18. Bovbjerg, D.H., Kim, Y.T., Schwab, R., Schmitt, K., DeBlasio, T., and Weksler, M.E. ACross-wiring@ of the immune response in old mice: increased autoantibody response despite reduced antibody response to nominal antigen. Cell. Immunol. 135:519-525 (1991).
19. Hara, H., Negoro, S., Miyata, S., Saiki, O., Yoshizaki, K., Tanaka, T., Igarashi, T., and Kishimoto, S. Age-associated changes in proliferative and differentiative response of human B cells and production of T cell-derived factors regulating B cell functions. Mech. Ageing Dev. 38:245-258 (1987).
20. Chopra, R.K., Nagel, J.E., Chrest, F.J., and Adler, W.H. Impaired phorbol ester and calcium ionophore induced proliferation of T cells from old humans. Clin. Exp. Immunol.70:456-462 (1987).
21. Pieri, C., Recchioni, R., Moroni, F., Marcheselli, F., and Damjanovich, S. The response of human lymphocytes to phytohemagglutinin is impaired at different levels during aging.Annals NY Acad. Sci. 673:110-119 (1992).
22. Schwab, R., Hausman, P.B., Rinnooy-Kan, E., and Weksler, M.E. Impaired T lymphocytes and normal monocyte response from elderly humans to the mitogenic antibodies Okt3 and Leu 4. Immunology 55:677-684 (1985).
23. Niks, M., Otto, M., Busova, B., and Stefanovic, J. Quantification of proliferative and suppressive responses of human T lymphocytes following conA stimulation. J. Immunol. Meth. 126:263-271 (1990).
24. Negoro, S., Hara, H., Miyata, S., Saiki, O., Tanaka, T., Yoshizaki, K., Igarashi, T., and Kishimoto, S. Mechanisms of age-related decline in antigen-specific T cell proliferative response: IL-2 receptor expresssion and recombinant IL-2 induced proliferative response of purified tac-positive T cells. Mech. Ageing Dev. 36:223-241 (1986).
25. Matour, D., Melnicoff, M., Kaye, D., and Murasko, D.M. The role of T cell phenotypes in decreased lymphoproliferation of the elderly. Clin. Immunol. Immunopathol.50:82-99 (1989).
26. Antonaci, S., Jirillo, E., Ventura, M.T., Garofalo, A.R., and Bonomo, L. Non-specific immunity in aging: deficiency of monocyte and polymorphonuclear cell-mediated functions. Mech. Ageing Dev. 24:367-375 (1984).
27. Komatsubara, S., Cinader, B., and Muramatsu, S. Functional competence of dendritic cells of ageing C57BL/6 mice. Scand. J. Immunol. 24:517-525 (1986).
28. Rich, E.A., Mincek, M.A., Armitage, K.B., Duffy, E.G., Owen, D.C., Fayen, J.D., Hom, D.L., and Ellner, J.J. Accessory function and properties of monocytes from healthy elderly humans for T lymphocyte responses to mitogen and antigen. Gerontology. 39:93-108 (1993).
29. Perkins, E.H., Massucci, J.M., and Glover, P.L. Antigen presentation by peritoneal macrophages from young and adult old mice. Cell. Immunol. 70:1-10 (1982).
30. Hallgren, H.M., Buckley, C.E. III, Gilbertsen, V.A., and Yunis, E.J. Lymphocyte phytohemagglutinin responsiveness, immunoglobulins and autoantibodies in aging humans. J. Immunol. 111:1101-1107 (1973).
31. Kishimoto, S., Tomino, S., Inomata, K., Kotegawa, S., Saito, T., Koroki, M., Mitsuya, H., and Hisamitsu, S. Age-related changes in the subsets and functions of human T lymphocytes. J. Immunol. 121:1173-1180 (1978).
32. Radl, J., Speers, J.M., Skvaril, F., Morell, A., and Hijmans, W. Immuno-globulin patterns in humans over 95 years of age. Clin. Exp. Immunol. 22:84-90 (1975).
33. Manoussakis, M.N., Tzioufas, A.G., Silis, M.P., Pange, P.J.E., Goudevenos, J., and Moutsopoulos, H.M. High prevalence of anti-cardiolipin and other autoantibodies in a healthy elderly population. Clin. Exp. Immunol. 69:557-565 (1987).
34. Xavier, R.M., Yamauchi, Y., Nakamura, M., Tanigawa, Y., Ishikura, H., Tsunematsu, T., and Kobayashi, S. Antinuclear antibodies in healthy aging people: a prospective study. Mech. Ageing. Dev. 78:145-154 (1995).
35. Hara, H., Negoro, S., Miyata, S., Saikii, O., Yoshizaki, K., Tanaka,T., Igarashi, T., and Kishimoto, S. Age-associated changes in proliferative and differentiative response of human B cells and production of T cell derived factors regulating B cell function. Mech. Ageing Dev. 38:245-258 (1987).
36. Weiner, H.L., Scribner, D.J., Schocket, A.L., and Moorhead, J.W. Increased proliferative response of human peripheral blood lymphocytes to anti-immunoglobulin antibodies in elderly people. Clin. Immunol. Immunopathol. 9:356-361 (1978).
37. George, A.J.T., and Ritter, M.A. Thymic involution with ageing: obsolescence or good housekeeping. Immunol. Today 17:267-272 (1996).
38. Flurkey, K., Stadecker, M., and Miller, R.A. Memory T lymphocyte hypo-responsiveness to non-cognate stimuli: a key factor in age-related immunodeficiency Eur. J. Immunol. 22:931-935 (1992).
39. Lerner, A., Yamada, T., and Miller, R.A. Pgp-1hi T lymphocytes accumulate with age in mice and respond poorly to Concanavalin A. Eur. J. Immunol. 19:977-982 (1989).
40. Utsuyama, M., Hirokawa, K., Kurashima, C., Fukayama, M., Inamatsu, T., Suzuki, K.,Hashimoto, W., and Sato, K. Differential age-change in the numbers of CD4+CD45RA+ and CD4+CD29+ T cell subsets in human peripheral blood. Mech.
Ageing Dev. 63:57-68 (1992).
41. De Paoli, P., Battstin, S., and Santini, G.F. Age-related changes in human lymphocyte subsets: progressive reduction of the CD4 CD45R (Suppressor inducer) population. Clin. Immunol. Immunopathol. 48:290-296 (1988).
42. Budd, R.C., Cerottini, J.C., Horvath, C., Bron, C., Pedrazzini, T., Howe, R.C., and MacDonald, H.R. Distinction of virgin and memory T lymphocytes; stable acquisition of the Pgp-1 glycoprotein concomitant with antigenic stimulation. J. Immunol. 138:3120-3129 (1987).
43. Mackay, C.R. Immunological Memory. Adv. Immunol. 53:217-265 (1993).
44. Gray, D. Immunological Memory. Annu. Rev. Immunol. 11:49-77 (1993).
45. Swain, S.L., Croft, M., Dubey, C., Haynes, L., Rogers, P., Zhang, X., and Bradley, L.M. From naive to memory T cells. Immunol. Revs. 150:143-167 (1996).
46. Shi, J., and Miller, R.A. Differential tyrosine-specific protein phosphorylation in mouse T lymphocyte subsets. J. Immunol. 151:730-739 (1993).
47. Miller, R.A. Accumulation of hyporesponsive, calcium extruding memory T cells as a key feature of age-dependent immune dysfunction. Clin. Immunol. Immunopathol.58:305-317 (1991).
48. Miller, R.A. Defective calcium signal generation in a T cell subset that accumulates in old mice. Annals NY Acad. Sci. 568:271-276 (1989).
49. Geppert, T.D., and Lipsky, P.E. Immobilized anti-CD3 induced T cell growth:comparison of the frequency of responding cells within various T cell subsets. Cell.Immunol. 133:206-218 (1991).
50. Tedder, T.F., Cooper, M.D., and Clement, L.T. Differential production of B cell growth and differentiation factors by distinct helper T cell subpopulations. J. Immunol.134:2989-2994 (1985).
51. Sanders, M.E., Makgoba, M.W., Sharrow, S.O., Stephany, D., Springer, T.A., Young, H.A., and Shaw, S. Human memory T lymphocytes express increased levels of three cell adhesion molecules (LFA-3, CD2, and LFA-1) and three other molecules (UCHL1,Cdw29, and Pgp-1) and have enhanced IFNgamma production. J. Immunol. 140:1401-1407 (1988).
52. Smith, S.H., Brown, M.H., Rowe, D., Callards, R.E., and Beverley, C.L. Functional subsets of human helper-inducer cells defined by a new monoclonal antibody, UCHL1. Immunology 58:63-70 (1986).
53. Horgan, K.J., Van Seventer, G.A., Shimizu, Y., and Shaw, S. Hyporesponsiveness of Anaive@ (CD45RA+) human T cells to multiple receptor-mediated stimuli but augmentation of responses by co-stimuli. Eur. J. Immunol. 20:1111-1118 (1990).
54. Sanders, M.E., Makgoba, M.W., June, C.H., Young, H.A., and Shaw, S. Enhanced responsiveness of human memory T cells to CD2 and CD3 receptor-mediated activation.Eur. J. Immunol. 19:803-808 (1989).
55. Rothstein, D.M., Yamada, A., Schlossman, S.F., and Morimoto, C. (1991), Cyclic regulation of CD45 isoform expression in a long term human CD4+CD45RA+ T cell line. J. Immunol.146:1175-1183 (1991).
56. Bell, E.B., and Sparshott, S.M. Interconversion of CD45R subsets of CD4 T cells in vivo. Nature 348:163-166 (1990).
57. Osterland, C.K., and St.Louis, E.A. Immune reactivity in aging- autologous mixed lymphocyte responses. Gerontology 38:301-307 (1992).
58. Bloom, E.T., Umehara, H., Bleackley, R.C., Okumura, K., Mostowski, H., and Babbitt, J.T. Age-related decrement in cytotoxic T lymphocyte (CTL) activity is associated with decreased levels of mRNA encoded by two CTL-associated serine esterase genes and the perforin gene in mice. Eur. J. Immunol. 20:2309-2316 (1990).
59. Bloom, E.T. Natural killer cells, lymphokine-activated killer cells, and cytolytic T lymphocyte: compartmentalization of age-related changes in cytolytic lymphocytes. J. Gerontol. 49:B85-92 (1994).
60. Ernst, D.N., Weigle, W.O., McQuitty, D.N., Rothermel, A.L., and Hobbs, M.V. Stimulation of murine T cell subsets with anti-CD3 antibody; age-related defects in the expression of early activation molecules. J. Immunol. 142:1413-1421 (1989).
61. Nagel, J.E., Chopra, R.K., Chrest, F.J., McCoy, M.T., Schneider, E.L., Holbrook, N.J., and Adler, W.H. Decreased proliferation, interleukin 2 synthesis, and interleukin 2 receptor expression are accompanied by decreased mRNA expression in phytohemagglutinin-stimulated cells from elderly donors. J. Clin. Invest. 81:1096-1102 (1988).
62. Gupta, S. Membrane signal transduction in T cells in aging humans. Annals NY Acad. Sci. 568:277-282 (1989).
63. Varga, Z.S., Bressani, N., Zaid, A.M., Bene, L., Fulop, T., Leovey, A., Fabris, N., and Damjanovich, S. Cell surface markers, inositol phosphate levels and membrane potential of lymphocytes from young and old human patients. Immunol. Lett.23:275-283 (1989/1990).
64. Proust, J.J., Filburn, C.R., Harrison, S.A., Buchholz, M.A., and Nordin, A.A. Age-related defect in signal transduction during lectin activation of murine T lymphocytes. J.Immunol. 139:1472-1478 (1987).
65. Pietro, R.D., Rana, R.A., Sciscio, A., Marmiroli, S., Billi, A.M., Cataldi, A., and Cocco, L. Age-related events in human active T lymphocytes: changes in the phospho-inositidase C activity. Biochem. Biophys. Res. Comm. 194:566-570 (1993).
66. Orson, F.M., Saadeh, C.K., Lewis, D.E., and Nelson, D.L. Interleukin 2 receptor expression by T cells in human aging. Cell. Immunol. 124:278-291 (1989).
67. Xu, X., Beckman, I., and Bradley, J. Age-related changes in the expression of IL-2 and high affinity IL-2-binding sites. Int. Arch. Allergy Immunol. 102:224-231 (1993).
68. Gillis, S., Kozak, R., Durante, M., and Weksler, M.E. Decreased production of and response to T cell growth factor by lymphocytes from aged humans. J. Clin. Invest. 67:937-942 (1981).
69. Chopra, R.K., Holbrook, N.J., Powers, D.C., McCoy, M.T., Adler, W.H., and Nagel, J.E. Interleukin 2, interleukin 2 receptor, and interferon gamma synthesis and mRNA expression in phorbol myristate acetate and calcium ionophore A23187-stimulated T cells from elderly humans. Clin. Immunol. Immunopathol. 53:297-308 (1989).
70. Daynes, R.A., Araneo, B.A., Ershler, W.B., Maloney, C., Li, G.Z., and Ryu, S.Y.Altered regulation of IL-6 production with normal aging. J. Immunol. 150:5219-5230 (1993).
71. Spencer, N.F.L., Norton, S.D., Harrison, L.L., Li, G.Z., and Daynes, R.A. Dys-regulation of Il-10 production with aging: possible linkage to the age-associated decline in DHEA and its sulfated derivative. Exp. Gerontol. 31:393-408 (1996).
72. Hobbs, M.V., Weigle, W.O., and Ernst, D.N. Interleukin 10 production by splenic CD4+ cells and cell subsets from young and old mice. Cell. Immunol. 154:264-272 (1994).
73. Crabtree, G.R., and Clipstone, N.A. Signal transmission between the plasma membrane and nucleus of T lymphocytes. Ann. Rev. Biochem. 63:1045-1083 (1994).
74. Altman, A., Coggeshall, K.M., and Mustelin, T. Molecular events mediating T cell activation. Adv. Immunol. 48:277-360 (1990).
75. Abbas, A., Lichtman, A., and Pober, J. Cellular and Molecular immunology. Philadelphia, W.B. Saunders Company.138-170 (1997).
76. Trebilcock, G.U., and Ponnappan, U. Evidence for lowered induction of nuclear factor Kappa B in activated human T lymphocytes during aging. Gerontol. 42:137-146 (1996).
77. Whisler, R.L., Beiqing, L., Wu, L.C., and Chen, M. Reduced activation of transcriptional factor AP-1 among peripheral blood T cells from elderly humans after PHA stimulation: restorative effect of phorbol diesters. Cell. Immunol. 152:96-109 (1993).
78. Whisler, R.L., Beiqing, L, and Chen, M. (1996), Age-related decreases in IL-2 production by human T cells are associated with impaired activation of nuclear transcriptional factors AP-1 and NFAT. Cell. Immunol. 169:185-195 (1996).
79. Riabowol, K., Schiff, J., and Gilman, M.Z. Transcription factor AP-1 activity is required for initiation of DNA synthesis and is lost during cellular aging. Proc. Natl. Acad. Sci. USA 89:157-161 (1992).
80.Verweij, C.L., Guidos, C., and Crabtree, G.R. Cell type specificity and activation requirements for NFAT-1 (nuclear factor of activated T cells) transactivational activity determined by a new method using transgenic mice to assay transactivation of an individual nuclear factor. J. Biol. Chem. 265:15,788 (1990).
81. Cockerill, P.N., Bert, A.G., Jenkins, F., Ryan, G.R., Shannon, M.F., and Vadas, M.A. Human granulocyte-macrophage colony-stimulating factor enhancer function is associated with cooperative interactions between AP-1 and NFATp/c. Mol. Cell. Biol. 15:2071-2079 (1995).
82. Todd, M.D., Grubby, M.J., Lederen, J.A., Lacy E., Lichtman, A.H., and Glimcher, L.A. Transcription of the interleukin 4 gene is regulated by multiple promoter elements. J. Exp. Med. 177:1663-1674 (1993).
83. Szabo, S.J., Gold, J.S., Murphy, T.L., and Murphy, K.M. Identification of cis-acting regulatory elements controlling interleukin 4 gene expression in T cells: roles for NF-Y and NFATc. Mol. Cell. Biol. 13:4793-4805 (1993).
84. Goldfeld, A.E., McCaffrey, P.G., Strominger, J.L., and Rao, A. Identification of a novel cyclosporin-sensitive element in the human tumor necrosis factor alpha gene promoter. J. Exp. Med. 178:1365-1379 (1993).
85. Sen, R., and Baltimore, D. Multiple nuclear factors interact with the immunoglobulin sequences. Cell 46:705 (1986).
86. Miyamoto, S., and Verma, I. M. Rel/NF kappa B/I kappa B story. Adv. Cancer Res. 66:255-292 (1995).
87. Siebenlist, U., Franzoso, and Brown, K. Structure, regulation and function of NF kappa B. Annu. Rev. Cell Biol. 10:405-455 (1994).
88. Grilli, M., Chiu, J.J.S., and Lenardo, M.J. NF kappa B and Rel: participants in a multiform transcriptional regulatory system. Int. Rev. Cytol. 143:1-62 (1993).
89. Baldwin, A. S., The NF kappa B and I kappa B proteins: new discoveries and insights. Annu. Rev. Immunol. 14:649-681 (1996).
90. Gilmore, T.D. Role of rel family genes in normal and malignant lymphoid cell growth. Cancer Surveys 15:69-87 (1992).
91. Mukhopadhyay, T., Roth, J.A., and Maxwell, S.A. Altered expression of the p50 subunit of the NF KAPPA B transcription factor complex in non-small cell lung carcinoma. Oncogene 11:999-1003 (1995).
92. Chang, C.C., Zhang, J., Lombardi, L., Neri, A., and Dalla-Favera, R. (1995), Rearranged NF kappa B-2 genes in lymphoid neoplasms code for constitutively active nuclear transactivatiors. Mol. Cell. Biol. 15:5180-5187 (1995).
93. Higgins, K.A., Perez, J.R., Coleman, T.A., Dorshkind, K., McComas, W.A., Sarmiento, U.M., Rosen, C.A., and Narayanan, R. Antisense inhibition of the p65 subunit of NF kappa B blocks tumorigenicity and causes tumor regression. Proc. Natl. Acad. Sci. 90:9901-9905 (1993).
94. Bours, V., Dejardin, E., Goujon-Letawe, E., Merville, M.P., and Castronovo, V. The NF kappa B transcription factor and cancer: high expression of NF kappa B and I kappa B related proteins in tumor cell lines. Biochem. Pharmacol. 47:145-149 (1994).
95. Beg, A.A., Ruben, S.M., Scheinman, R.I., Haskill, S., Rosen, C.A., and Baldwin, A.S. I kappa B interacts with the nuclear localization sequences of the subunits of NF kappa B: a mechanism for cytoplasmic retention. Genes Dev. 6:1899-1913 (1992).
96. Baeuerle, P.A., and Baltimore, D. IkappaB: A specific inhibitor of the NF kappa B transcription factor. Science 242:540-546 (1988).
97. Beg, A.A., and Baldwin, A.S. The I kappa B proteins: multifunctional regulators of Rel/NF kappa B transcription factors. Genes Dev. 7:2064-2070 (1993).
98. Sen, R., and Baltimore, D. Inducibility of kappa immunoglobulin enhancer-binding protein NF kappa B by a post translational mechanism. Cell 47:921-928 (1986).
99. Muller, C. W., and Harrison, S.C. The structure of the NFkappaB p50: DNA-complex a starting point for analyzing the Rel familiy. Febs. Lett. 369:113-117 (1995).
100. Muller, C.W., Rey, F.A., Sodeoka, M., Verdine, G.L., and Harrison, S.C. Structure of the NF kappa B p50 homodimer bound to DNA. Nature 373:311-317 (1995).
101. Nolan, G.P. NFAT -AP-1 and Rel-bZIP hybid vigor and binding under the influence. Cell 77:795-798 (1994).
102. Jain, J., Burgeon, E., Badalian, T.M., Hogan, P.G., and Rao, A. A similar DNA-binding motif in NFAT familiy proteins and the Rel homology domain. J.Biol. Chem.270:4138-4145 (1995).
103. Stein, B., Baldwin, A.S., Ballard, D.W., Greene, W.C., Angel, P., and Herrlich, P. Cross coupling of the NF kappa B p65 and fos/jun transcription factors produces potentiated biological function. EMBO J. 12:3879-3891 (1993).
104. Lernbecher, T., Kistler, B., and Wirth, T. Two distinct mechanisms contribute to the constitutive activation of RelB in lymphoid cells. EMBO J.13:4060-4069 (1994).
105. Bull, P., Morley, K.L., Hoekstra, M.F., Hunter, T., and Verma, I.M. The mouse c- rel protein has an N-terminal regulatory domain and C-terminal transcriptional transactivation domain. Mol. Cell. Biol. 10:5473-5485 (1990).
106. Kamens, J., Richardson, P., Mosialos, G., Brent, R., and Gilmore, T. Oncogenic transformation by v-rel requires an amino-terminal activation domain. Mol. Cell. Biol. 10:2840-2847 (1990).
107. Schmitz, M.L., and Baeuerle, P.A. The p65 subunit is responsible for the strong transcription activating potential of NF kappa B. EMBO J. 10:3805-3817 (1991).
108. Fujita, T., Nolan, G.P., Ghosh, S, and Baltimore, D. Independent modes of transactivation by the p50 and p65 subunits of NF kappa B. Genes Dev. 6:775-787 (1992).
109. Kang, S.M., Tran, A.C., Grilli, M., and Lenardo, M.J. NF kappa B subunit regulation in nontransformed CD4+ T lymphocytes. Science 256:1452-1456 (1992).
110. Plaskin, D., Baeuerle, P.A., and Eisenbach, L. KBF1 (p50 NF kappa B homodimer) acts as a repressor of H-2K b gene expression in metastatic tumor cells. J. Exp. Med.177:1651-1662 (1993).
111. Weih, F., Carrasco, D., and Bravo, R. Constitutive and inducible Rel/NF kappa B activities in mouse thymus and spleen. Oncogene 9:3289-3297 (1994).
112. Brown, A.M., Linhoff, M.W., Stein, B., Wright, K.L., Baldwin, A.S., Basta, P.V., and Ting, J.P.Y. Function of NF kappa B/Rel binding sites in the major histocompatability complex class II invariant chain promoter is dependent on cell-specfic binding of different NF kappa B/Rel subunits. Mol. Cell. Biol. 14:2926-2935 (1994).
113. Weih, F., Lira, S.A., and Bravo, R. Overexpression of RelB in transgenic mice does not affect I kappa B-alpha levels: differential regulation of RelA and RelB by the inhibitor protein. Oncogene 12:445-449 (1995).
114. Miyamoto, S., Schmitt, M.J., and Verma, I.M. Qualitative changes in the subunit compostition of kappa B-binding complexes during murine B-cell differentiation. Proc. Natl. Acad. Sci. USA 91:5056-5060 (1994).
115. Pimentel-Muinos, F.X., Mazana, J., and Fresno, M. Biphasic control of nuclear factor kappa B activation by the T cell receptor complex: role of tumor necrosis factor alpha. Eur. J. Immunol. 25:179-186 (1995).
116. Verma, I. M., Stevenson, J.K., Schwarz, E.M., Van Antwerp, D., and Miyamoto, S. Rel/NF kappa B/I kappa B family: intimate tales of association and dissociation. Genes Dev. 9:2723-2735 (1995).
117. Blank, V., Kourilsky, P., and Israel, A. NFkappaB and related proteins:Rel/dorsal homologies meet ankyrin-like repeats. Trends Biochem. Sci. 17:135-140 (1992).
118. Hatada, E.N., Naumann, M., and Scheidereit, C. Common structural constituents confer I kappa B activity to NF kappa B p105 and I kappa B/MAD3. EMBO12:2781-2788 (1993).
119. Baeuerle, P.A., and Baltimore, D. Activation of DNA-binding activity in an apparently cytoplasmic precursor of the NF kappa B transcription factor. Cell :211-217 (1988).
120. Thompson, J.E., Phillips, R.J., Erdjument-Bromage, H., Tempst, P., and Ghosh, S. I kappa B-beta regulates the persistent response in a biphasic activation of NF kappa B. Cell 80:573.-582 (1995).
121. Ernst, M.K., Dunn, L.L., and Rice, N.R. The PEST-like sequence of I kappa B-alpha is responsible for inhibition of DNA binding but not for cytoplasmic retention of c-Rel or Rel A homodimers. Mol. Cell. Biol. 15:872-882 (1995).
122. Zabel, U., and Baeuerle, P.A. Purified Human I kappa B can rapidly dissociate the complex of the NF kappa B transcription factor with its cognate DNA. Cell 61:255-265 (1990).
123. Zabel, U., Henkel, T., Silva, M.D.S., and Baeuerle, P.A. Nuclear uptake control of NF kappa B by MAD-3, an I kappa B protein present in the nucleus. EMBO J. 12:201-211 (1993).
124. Cressman, D.E., and Traub, R. I kappa B-alpha can localize in the nucleus but shows no direct transactivation potential. Oncogene 8:2567-2573 (1993).
125. Arenzana-Seisdedos, F., Thompson, J., Rodriguez, M.S., Bachelerie, F., Thomas, D., and Hay, R.T. Inducible nuclear expression of newly sythesized I kappa Balpha negatively regulates DNA-binding and transcriptional activities of NF kappa B. Mol.Cell Biol. 15:2689-2696 (1995).
126. Klement, J.F., Rice, N.R., Car, B.D., Abbondanzo, S.J., Powers, G.D., Bhatt, H., Chen, C.H., Rosen, C.A., and Stewart, C.L. (1996), IkappaBalpha deficiency results in a sustained NF kappa B response and severe widespread dematitis in mice. Mol. Cell. Biol. 16:2341-2349 (1996).
127. Brown, K., Park, S., Kanno, T., Franzoso, G., and Siebensist, U. Mutual regulation of the transcriptional activator NF kappa B and its inhibitor, I kappa B-alpha. Proc. Natl. Acad. Sci. USA.90:2532-2536 (1993).
128. Sun, S.C., Ganchi, P.A., Ballard, D.W., and Greene, W.C. NF kappa B controls expression of inhibitor I kappa B-alpha: evidence for an inducible autoregulatory pathway. Science 259:1912-1915 (1993).
129. Henkel, T., Machleidt, T., Alkalay, I., Kronke, M., Ben-Neriah, Y., and Baeuerle, P.A. Rapid proteolysis of I kappa B-alpha is necessary for activation of transcription factor NF kappa B. Nature 365:182-185 (1993).
130. Beg, A.A., Finco, T.S., Nantermet, P.V., and Baldwin, A.S. Tumor necrosis factor and interleukin 1 lead to phosphorylation and loss of I kappa B-alpha: a mechanism for NFkappaB activation. Mol. Cell. Biol.13:3301-3310 (1993).
131. Trebilcock, G.U. and Ponnappan, U. Nuclear factor Kappa B induction in CD45RO+ and CD45RA+ T cell subsets during aging. Mech.ageing.Dev. (In press)
132. Ghosh, S., and Baltimore, D. Activation in vitro of NF kappa B by phoshorylation of its inhibitor I kappa B. Nature 344:678-682 (1990).
133. Shirakawa, F., and Mizel, S.B. In vitro activation and nuclear translocation of NF kappa B catalyzed by cyclic amp-dependent protein kinase and protein kinase C. Mol.Cell. Biol.9 :2424-2430 (1989).
134. Jamieson, C., McCaffrey, P.G., Rao, A., and Sen, R. Physiologic activation of T cells via the T cell receptor induces NF kappa B. J. Immunol. 147:416-420 (1991).
135. Meichle, A., Schutze, S., Hensel, G., Brunsing, D., and Kronke, M. Protein kinase C-independent activation of nuclear factor kappa B by tumor necrosis factor. J. Biol. Chem. 265:8339-8343 (1990).
136. Schutze, S., Potthoff, K., Malchleidt, T., Berkovic, D., Wiegmann, K., and Kronke, M. TNF activates NF kappa B by phosphatidylcholine-specific phospholipase C-induced Aacidic@ sphingomyelin breakdown. Cell 71:765-776 (1992).
137. Diaz-Meco, M.T., Dominguez, I., Sanz, L., Dent, P., Lozano, J., Municio, M.M., Berra, Hay, R.T., Sturgill, T.W., and Moscat, J. (1994), zeta PKC induces phosphorylation and inactivation of I kappa B-alpha in vitro. EMBO J. 13:2842-2848 (1994).
138. Diaz-Meco, M.T., Berra, E., Municio, M.M., Sanz, L., Lozano, J., Dominguez, I., Diaz-Golpe, V., DeLera, M.T.L., Alcami, J., Paya, C.V., Arenzana-Seisdedos, F., Virelizier, J.L., and Moscat, J. A dominant negative protein kinase C zeta subspecies blocks NF kappa B activation. Mol. Cell. Biol. 13:4770-4775 (1993).
139. Muller, G., Ayoub, M., Storz, P., Rennecke, J., Fabbro, D., and Pfizenmaier, K. PKC zeta is a molecular switch in signal transduction of TNF-alpha, bifunctionally regulated by ceramide and arachidonic acid. EMBO J. 14:1961-1969 (1995).
140. Schreck, R., Rieber, P., and Baeuerle, P.A. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF kappa B transcription factor and HIV-1. EMBO J. 10:2247-2258 (1991).
141. Suzuki, Y.J., Mizuno, M., and Packer, L. Transient overexpression of catalase does not inhibit TNF-alpha of PMA- induced NF kappa B activation. Biochem. Biophys. Res. Comm. 210:537-541 (1995).
142. Brennan, P., and O'Neill, L.A.J. Effects of oxidants and antioxidants on nuclear factor kappaB activation in three different cell lines: evidence against a universal hypothesis involving oxygen radicals. Biochem. Biophys. Acta. 1260:167-175 (1995).
143. DiDonato, J.A., Mercurio, F., and Karin, M. Phosphorylation of I kappaB -alpha precedes but is not sufficient for its dissociation from NF kappa B. Mol. Cell. Biol.15:1302-1311 (1995).
144. Alkalay, I., Yaron, A., Hatzubai, A., Jung, S., Avraham, A., Gerlitz, O., Pashut-Lavon, I., and Ben-Neriah, Y. In vivo stimulation of I kappa B phosphorylation is not sufficient to activate NF kappa B. Mol. Cell. Biol. 15:1294-1301 (1995).
145. Brown, K., Gerstberger, S., Carlson, L., Franzoso, G., and Siebenlist, U. Control of I kappa B-alpha proteolysis by site-specific signal-induced phosphorylation. Science 267:1485-1488 (1995).
146.Traenckner, E.B.M., Pahl, H.L., Henkel, T., Schmidt, K.N., Wilk, S., and Baeuerle, P.A. Phosphorylation of human I kappa B-alpha on serines 32 and 36 control I kappa B-alpha proteolysis and NF kappa B activation in response to diverse stimuli. EMBO J. 14:2876-2883 (1995).
147. Mellits, K.H., Hay, R.T., and Goodbourn, S. Proteolytic degradation of MAD3 (I kappa B-alpha) and enhanced processing of the NF kappa B precursor p105 are obligatory steps in the activation of NFkappaB. Nucl. Acids Res. 21:5059-5066 (1993).
148. Schierer, D.C., Brockman, J.A., Chen, Z., Maniatis, T., and Ballard D.W. Signal-induced degradation of I kappa B-alpha requires site-specific ubiquitination. Proc. Natl. Acad. Sci. USA 92:11259-11263 (1995).
149. Baldi, L., Brown, K., Franzoso, G., and Siebenlist, U. Critical role for lysines 21 and 22 in signal-induced ubiquitin-mediated proteolysis of I kappa B-alpha. J. Biol.Chem. 271:376-379 (1996).
150.Chen, Z., Hagler, J., Palombella, V.J., Melandri, F., Scherer, D., Ballard, D., and Maniatis, T. Signal-induced site-specific phosphorylation targets I kappa B-alpha to the ubiquitin-proteasome pathway. Genes Dev. 9:1586-1597 (1995).
151. Li, C.C., Dai, R.M., and Longo, D.L. Inactivation of NF kappa B inhibitor I kappa B-alpha: ubiquitin-dependent proteolysis and its degradation product. Biochem.Biophys. Res.Comm. 215:292-301 (1995).
152. Alkalay, I., Yaron, A., Hatzubai, A., Orian, A., Ciechanover, A. and Ben Neriah, Y.Stimulation dependent I kappa B-alpha phosphorylation marks the NF kappa B inhibitor for degradation via the ubiquitin-proteasome pathway. Proc. Natl. Acad. Sci. USA 92:10599-10603 (1995).
153. Coux, O., Tanaka, K. and Goldberg, A.L. Structure and functions of the 20S and 26S proteasomes. Ann. Rev. Biochem. 65:801-847 (1996).
154. Traenckner, E.B.M., Wilk,S., and Baeuerle, P.A. A proteasome inhibitor prevents activation of NF kappa B and stabilizes a newly phosphorylated form of I kappa B-alpha that is still bound to NF kappa B. EMBO J. 13:5433-5441 (1994).
155. Chen, Z. J., Parent, L., and Maniatis, T. Site-specific phosphorylation of I kappa B-alpha by a novel ubiquitination-dependent protein kinase activity. Cell 84:853-862 (1996).
156. Mercurio, F., Zhu, H., Murray, B.W., Shevchenko, A., Bennet, B., Li, J.W., Young, D., Barbosa, M., Mann, M., Manning, A. and Rao, A. IKK1 and IKK2 :Cytokine-activated I kappa B kinases essential for NF kappa B activation. Science 278:860-866 (1997).
157. Woronicz, J.D., Gao, X., Cao, Z., Rothe, M., Goeddel, D.V. I kappa B Kinase-beta: NF kappa B activation and complex formation with I kappa B kinase-alpha and NIK. Science 278: 866-869 (1997).
158. Verma, I.M. and Stevenson, J. I kappa B kinase: Beginning, not the end. Proc. Natl. Acad. Sci. 94: 11758-11760 (1997).
159. Cogswell, P.C., Scheinman, R.I., and Baldwin, A.S. Promoter of the human NF kappa B p50/p105 gene. J. Immunol. 150:2794-2804 (1993).
160. Ten, R.M., Paya, C.V., Israel, N., LeBail, O., Mattei, M.G., Virelizier, J.L., Kourilsky, P., and Israel, A. The characterization of the promoter of the gene encoding the p50 subunit of NF kappa B indicates that it participates in its own regulation. EMBO J. 11:195-203 (1992).
161. Hoyos, B., Ballare, D.W., Bohnlein, E., Siekevitz, M., and Greene, W.C. Kappa B-specific DNA binding proteins: role in the regulation of human interleukin -2 gene expression. Science 244:457-460 (1989).
162. Pimental-Muinos, F.X., Munoz-Fernandez, M.A., and Fresno, M. Control of T lymphocyte activation and IL-2 receptor expression by endogenously secreted lymphokines. J. Immunol. 152:5714-5722 (1994).
163. Pimental-Muinos, F.X., Mazana, J., and Fresno, M. Regulation of interleukin 2 receptor-alpha chain expression and nuclear factor kappa B activation by protein kinase C in T lymphocytes. J. Biol. Chem. 269:24424-24429 (1994).
164.Kontgen, F., Grumont, R.J., Strasser, A., Metcalf, D., Li, R., Tarlinton, D., and Gerondakis, S. Mice lacking the c-rel proto-oncogene exhibit defects in lymphocyte proliferation, humoral immunity, and interleukin-2 expression .Genes Dev. 9:1965-1977 (1995).
165. Gerondakis, S., Strasser, A., Metcalf, D., Grigoriadis, G., Scheerlinck, J.P.Y., and Grumont, R.J. Rel-deficient T cells exhibit defects in production of interleukin 3 and granulocyte-macrophage colony stimulating factor. Proc. Natl. Acad. Sci. USA 93:3405-3409 (1996).
166. Burkly, L., Hession, C., Ogata, L., Reilly, C., Marconi, L.A., Olson, D., Tizard, R., Cate, R., and Lo, D. Expression of relB is required for the development of thymic medulla and dendritic cells. Nature 373:531-536 (1995).
167. Weih, F., Carrasco, D., Durham, S.K., Barton, D.S., Rizzo, C.A., Ryseck, R.P., Lira, S.A., and Bravo, R. Multiorgan inflammation and hematopoietic abnormalities in mice with a targeted disruption of RelB, a member of the NFkappaB/Rel familiy. Cell 80:331-340 (1995).
168. Sha, W.C., Liou, H.C., Tuomanen, E.I., and Baltimore, D. Targeted disruption of the p50 subunit of NF kappa B leads to multifocal defects in immune responses. Cell 80:321-330 (1995).
169. Beg, A.A., Sha, W.C., Bronson, R.T., Ghosh, S., and Baltimore, D. Embryonic lethality and liver degeneration in mice lacking the RelA component of NFkappaB. Nature 376:167-170 (1995).
170. Shibuya, H., Yoneyama, M., Taniguchi, T. Involvement of a common transcription factor in the regulated expression of IL-2 and IL-2 receptor genes. Int. Immunol. 1:43-49 (1989).
171. Albright, J.W., Zuniga-Pflucker, J.C., and Albright, J.F. Transcriptional control of IL-2 and IL-4 in T cells of young and old mice. Cell. Immunol. 164:170-175 (1995).
172. Dimiri, G.P., Hara, E., and Campisi, J. Regulation of two E2F-related genes in presenescent and senescent human fibroblasts. J. Biol. Chem. 269:16180-16186 (1994).
173. Aggarwal, B.B., Totpal, K., LaPushin, R., Chaturvedi, M.M., Pereira-Smith, O.M., and Smith, J.R. Diminished responsiveness of senescent normal human fibroblasts to TNF-dependent proliferation and interleukin production is not due to its effect on the receptors or on the activation of a nuclear factor NF kappa B. Exp. Cell Res. 218:381-388 (1995).
174. Heydari, A.R., Wu, B., Takahashi, R., Strong, R., and Richardson, A. Expression of heat shock protein 70 is altered by age and diet at the level of transcription. Mol. Cell. Biol. 13:2909-2918 (1993).
175. Heydari, A.R., Takahashi, R., Gutsmann, A., You, S., and Richardson, A. Hsp70 and aging. Experentia 50:1092-1098 (1994).
176. Pahlavani, M.A., Harris, M.D., and Richardson, A. The age-related decline in the induction of IL-2 transcription is correlated to changes in the transcription factor NFAT. Cell. Immunol. 165:84-91 (1995).
177. Kazmi, S.M.I., Plante, R.K., Visconti, V., Taylor, G.R., Zhou, L., and Lau, C.Y. (1995), Suppression of NFkappaB activation and NFkappaB dependent gene expression by tepoxalin, a dual inhibitor of cyclooxygenase and 5-lipoxygenase. J. Cell. Biochem. 57:299-310 (1995).
178. Scheinman, R.I., Cogswell, P.C., Lofquist, A.K., and Baldwin, A.S. Role of transcriptional activation of IkappaBalpha in mediation of immunosuppression by glucocorticoids. Science 270:283-286 (1995).
179. Auphan, N., DiDonato, J.A., Rosette, C., Helmberg, A., and Karin, M. Immuno-suppression by glucocorticoids: inhibition of NFkappaB activity through induction of IkappaBalpha synthesis. Science 270:286-290 (1995).
180. Kopp, E., and Ghosh, S. Inhibition of NFkappaB by sodium salicylate and aspirin. Science 265:956-959 (1994).
181. Shibatani, T., Nazir, M., and Ward, W.F. Alteration of rat liver 20S proteasome activities by age and food restriction. J. Gerontol. 51A:B316-322 (1996).
182. Ohtsuka, H., Takahashi, R., and Goto, S. Age-related accumulation of high- molecular weight ubiquitin protein conjugates in mouse brains. J. Gerontol. 50A:B277-283 (1995).
183. Vinitsky, A., Michaud, C., Powers, J.C., and Orlowski, M. Inhibition of the chymotrypsin-like activity of the pituitary multicatalytic proteinase complex. Biochemistry 31:9421-9428 (1992).
184. Ustrell, V., Realini, C., Pratt, G., and Rechsteiner, M. Human lymphoblast and erythrocyte multicatalytic proteases: differential peptidase activities and responses to the 11S regulator. Febs. Lett. 376:155-158 (1995).
185. Goldberg, A.L., and Rock, K.L. Proteolysis, proteasomes, and antigen presentation. Nature 357:375-379 (1992).
186. Gaczynska, M., Rock, K.L., and Goldberg, A.L. gamma-Interferon and expression of MHC genes regulate peptide hydrolysis by proteasomes. Nature 365:264-267 (1993).
187. Boes, B., Hengel, H., Ruppert, T., Multhaup, G., Koszinowski, U.H., and Kloetzel, P.M. Interferon gamma stimulation modulates the proteolytic activity and cleavage site preference of 20S mouse proteasomes. J. Exp. Med. 179:901-909 (1994).
188. Pagano, M., Tam, S.W., Theodoras, A.M., Beer-Romero, P., Del Sal, G., Chau, V.,Yew, P.R., Draetta, G.F., and Rolfe, M. Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science 269:682-685 (1995).
189. Murray, A. Cyclin ubiqutination: the destructive end of mitosis. Cell 81:149-152 (1995).
190. Sadoul, R., Fernandez, P.A., Quiquerez, A.L., Martinou, I., Maki, M., Schroter, M., Becherer, J.D., Irmler, M., Tschopp, J., and Martinou, J.C. Involvement of the proteasome in the programmed cell death of NGF-deprived symphathetic neurons. EMBO J.15:3845-3852 (1996).
191. Grimm, L.M., Goldberg, A.L., Poirier, G.G., Schwartz, L.M., and Osborne, B.A. Proteasomes play an essential role in thymocyte apoptosis. EMBO J. 15:3835-3844 (1996).
192. Sidman, C.L., Luther, E.A., Marshall, J.D., Nguyen, K.A., Roopenian, D.C., and Worthen, S.M. Increased expression of major histocompatibility complex antigens on lymphocytes from aged mice. Proc. Natl. Acad. Sci. USA 84:7624-7628 (1987).
193. Witkowski, J.M., Gorgas, G., and Miller, R.A. Reciprical expression of p- glycoprotein and TAP1 accompanied by higher expression of MHC Class I antigens in T cells of old mice. J. Gerontol. 51A:B76-82 (1996).
194. Trebilcock, G.U. and Ponnappan, U. Decreased proteasome mediated degradation in T cells from the elderly: a role in immune senescence. (Submitted)